Giaconda

Giaconda (GIA)

Stock Code

GIA

Stock Exchange

ax

Giaconda (GIA) develop medical therapies that provides relief for patients suffering from serious gastointestinal (GI) diseases and disorders. Its product portfolio comprises of four therapeutic products and a pre-colonoscopy bowel preparation. These products mainly deal with approved and accepted compounds. The company was founded in 2004 as a vehicle to commercialise therapies for gastointestinal diseases and disorders. GIA was listed on the ASX in Sep 2005.

Giaconda Dividends

18 October, 2010 - 01:09

Read about the list of dividend records for Giaconda. The dividend a corporation pays is the amount of money, normally a portion of the profits, a board of directors distributes to the ordinary shareholders of the corporation. If Giaconda Limited has released a dividend, you may be eligible to receive GIA dividends if the share trader the company's shares on the ex-dividend date. If you are interested in receiving a dividend, you must purchase the shares before the ex dividend date.

Syndicate content

Recommended Websites